Chemotherapy-Induced Cognitive Impairment: A First-Person Account of "Chemo Brain" and Its Impact on Professional Function
Key Insights
A journalist undergoing chemotherapy and immunotherapy for gastrointestinal cancer (search) describes experiencing cognitive side effects, including reduced focus and mental fogginess, after completing Round 1 of treatment.
The author reports that complex investigative writing tasks that previously took a single day now require a week of shorter sessions due to diminished concentration stamina.
This first-person narrative highlights the real-world functional impact of chemotherapy-related cognitive impairment, often termed "chemo brain," on professional and daily life.
A journalist chronicling his experience with cancer treatment has provided a candid account of the cognitive limitations imposed by chemotherapy and immunotherapy, offering a window into the functional realities of "chemo brain" — a phenomenon widely recognized in oncology but rarely documented with such granular, real-time detail.
The author, who writes under the banner of "The Chemo Chronicles," is undergoing treatment for a gastrointestinal cancer (search) and has completed one round of combined chemotherapy and immunotherapy infusions, with Round 2 scheduled to begin shortly thereafter.
The Nature of Cognitive Side Effects
Following his first round of treatment, the author describes a constellation of mild but persistent side effects. He reports feeling "fuzzy," characterizing his mental state as "perhaps 15% short of a sharp focus." Additional symptoms include moments of dizziness upon standing too quickly, nocturnal awakenings, and a somewhat depressed appetite. These symptoms, while described as "mild or absent" in his initial assessment, proved to have meaningful consequences when he attempted to resume complex professional work.
A Real-World Stress Test: Investigative Writing on Chemotherapy
The cognitive impact became unmistakable when the author undertook an investigative piece concerning a former city council member. Under normal circumstances — what he terms "BC, Before Cancer" — his workflow for complex stories involved gathering information over time, shaping the narrative, drafting, and then completing a final intensive editing session: "lock myself and my laptop in our spare bedroom for most of a day to push through a final rewrite and edit."
On chemotherapy, this process broke down. "Instead of a single, intensive marathon, I was forced into a relay race with myself — working an hour at a time before my focus evaporated," he writes. A final edit that would typically be completed in a single day-long session instead stretched across an entire week of shorter writing periods.
Implications for Professional Identity
The author frames this experience as more than a logistical inconvenience; it represents a challenge to his self-concept. He describes the need for "tinkering with psychological scaffolding that has been holding up my own self-image as well as my public persona, which have been taking a bit hit." The acknowledgment of these limits, he notes, is "a wake-up call," with the recognition that "there will be other accommodations down the road as treatment continues."
The account also touches on the broader life adjustments required during active cancer treatment. The author declined a colleague's request to pursue an election-related news tip, explaining that chemotherapy is "taxing my energy and attention, prompting me to put most worldly issues on the back burner for a while."
This first-person narrative underscores the gap between clinical descriptions of chemotherapy-related cognitive impairment and its lived experience — particularly for professionals whose work demands sustained intellectual focus. As the author concludes, quoting an old adage: "Know yourself. I'm learning."